ACM
AMRX icon

Argent Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Argent Capital Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-121,445
Closed -$1.72M – 197
2019
Q1 		$1.72M Buy
121,445
+31,375
+35% +$415K 0.06% 112
2018
Q4 		$1.22M Sell
90,070
-45,050
-33% -$812K 0.06% 123
2018
Q3 		$3M Buy
135,120
+81,035
+150% +$1.71M 0.1% 95
2018
Q2 		$888K Buy
+54,085
New +$949K 0.03% 146

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Argent Capital Management's AMRX Position: Q2 2019 in Review

Argent Capital Management sold out of Amneal Pharmaceuticals (AMRX) in Q2 2019, closing a stake of 121,445 shares — an estimated $1.72M sold.

Argent Capital Management first reported a position in AMRX in Q2 2018 and held it in 4 quarters. The position peaked at $3M in Q3 2018. 129 funds tracked by Wall St. Rank hold AMRX as of Q2 2019.

  • Argent Capital Management reported no remaining Amneal Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Argent Capital Management sold 121,445 Amneal Pharmaceuticals shares in Q2 2019, an estimated $1.72M.
  • Argent Capital Management first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 4 quarters.
  • Argent Capital Management's Amneal Pharmaceuticals position peaked at $3M in Q3 2018.
  • 129 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2019.

Based on Argent Capital Management's 13F filing for Q2 2019, filed 15 Aug 2019.